Pharmacovigilance Risk Assessment Committee (PRAC): 30 September - 3 October 2024

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Date

- ,

Location

European Medicines Agency, Amsterdam, the Netherlands

Documents

Share this page